Product Information
PROCTO-MED HC 2.5% CREAM is a generic product labeled by Leading Pharma, LLC, priced at $0.2350 per GM under NDC 69315031228. Its NADAC has been published 337 times since Apr 22, 2020.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AT.
Strength
25 mg/g
Manufacturer
Leading Pharma, LLCNDC
69315031228
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
HYDROCORTISONEApproval Type
Generic (ANDA)
FDA Application
ANDA085025FDA Approved
Before 1982
TE Code
AT
On Market Since
2/14/2020
Pharmacological Classes
Price Statistics
The NADAC for PROCTO-MED HC 2.5% CREAM has been published 337 times since Apr 22, 2020, and over the history we have for it it has declined 49.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2350 per GM |
|---|---|
| All-time high | $0.4656 (May 13, 2020) |
| All-time low | $0.2040 (Nov 20, 2024) |
| 52-week high | $0.2641 |
| 52-week low | $0.2345 |
| Median price | $0.2687 |
| Average price | $0.2966 |
| Largest weekly change | -23.1% (Nov 20, 2024) |
| Weeks tracked | 337 |
| Tracking since | Apr 22, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the HYDROCORTISONE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Leading Pharma, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
HYDROCORTISONE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROCTO-MED HC 2.5% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for PROCTO-MED HC 2.5% CREAM, manufactured by Leading Pharma, LLC, is $0.2350 per GM (NDC 69315031228), effective Sep 30, 2026.
How has the price of PROCTO-MED HC 2.5% CREAM changed over time?
Over the history we have for it, the NADAC for PROCTO-MED HC 2.5% CREAM has declined 49.5%. It has been tracked across 337 weekly CMS publications since Apr 22, 2020.
What are the highest and lowest recorded NADAC prices for PROCTO-MED HC 2.5% CREAM?
Since Apr 22, 2020, the NADAC for PROCTO-MED HC 2.5% CREAM has ranged from a low of $0.2040 (Nov 20, 2024) to a high of $0.4656 (May 13, 2020), with a median of $0.2687 per GM.
Are there cheaper alternatives to PROCTO-MED HC 2.5% CREAM?
No other NADAC-published product currently shares the active ingredient and strength of PROCTO-MED HC 2.5% CREAM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PROCTO-MED HC 2.5% CREAM?
PROCTO-MED HC 2.5% CREAM (NDC 69315031228) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.